UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Journal of clinical oncology, 2002-02, Vol.20 (3), p.719-726

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3107-3112

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2 -Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2023-03, Vol.41 (9), p.1638-1645

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2285-2291

2001

Link zum Volltext

Verfügbarkeit prüfen

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Oncology, 2001-01, Vol.61 (2), p.37-42

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2002-02, Vol.20 (3), p.719-726

Vogel, C. L.

2002

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3110-3116

1999

Link zum Volltext

Verfügbarkeit prüfen

Abstract CT026: Phase I trial of HuMab-5B1 (MVT-5873), a novel monoclonal antibody targeting sLea, in patients with advanced pancreatic cancer and other CA19-9 positive malignancies

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT026-CT026

2016

Link zum Volltext

Verfügbarkeit prüfen

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

Cancer chemotherapy and pharmacology, 2011-08, Vol.68 (2), p.539-545

2011

Link zum Volltext

Verfügbarkeit prüfen

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

Journal of neuro-oncology, 2002-05, Vol.57 (3), p.231-239

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Journal of clinical oncology, 2002-02, Vol.20 (4), p.937-940

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Journal of clinical oncology, 2002-02, Vol.20 (4), p.937-940

Vaughn, D. J.

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-B25: Preliminary phase I data comparing HuMab-5B1 (MVT-5873), a monoclonal antibody targeting sLea, as a single agent and in combination with first line nab-paclitaxel and gemcitabine in patients with CA19-9 positive pancreatic cancer

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.LB-B25-LB-B25

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting Hypoxia and AKR1C3 with PR104 in Patients with Acute Leukemia

Blood, 2012-11, Vol.120 (21), p.3615-3615

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract B278: PR610: A novel hypoxia-selective tyrosine kinase inhibitor in phase I clinical trial

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B278-B278

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel immunologic and biologic therapies for breast cancer

Current oncology reports, 2000-12, Vol.2 (6), p.582-586

Gutheil, J C

2000

Link zum Volltext

Verfügbarkeit prüfen

Targeted Antiangiogenic Therapy for Cancer Using Vitaxin: A Humanized Monoclonal Antibody to the Integrin ανβ3

Clinical cancer research, 2000-08, Vol.6 (8), p.3056

2000

Link zum Volltext

Verfügbarkeit prüfen

Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21

Human pathology, 1989-12, Vol.20 (12), p.1176-1180

1989

Link zum Volltext

Verfügbarkeit prüfen

RAS gene activation in acute myelogenous leukemia: Analysis by in vitro amplification and dna base sequence determination

Genes chromosomes & cancer, 1990-05, Vol.2 (1), p.71-77

1990

Link zum Volltext

Verfügbarkeit prüfen

RAS gene product expression in blood and marrow smears of patients with acute leukemia: Importance of fixation

Pathology, 1990, Vol.22 (2), p.77-81

1990

Link zum Volltext

Verfügbarkeit prüfen

Rapid and sensitive high-performance liquid chromatographic assay for novobiocin in human serum

Journal of chromatography. B, Biomedical applications, 1994-04, Vol.655 (1), p.147-152

1994

Link zum Volltext

Verfügbarkeit prüfen

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Journal of clinical oncology, 2001-03, Vol.19 (5), p.1444-1454

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3793-3803

1999

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1452-1458

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Biological And Medical Sciences
(13)
Female
(12)
Medical Sciences
(12)
Oncology
(12)
Middle Aged
(11)
Pharmacology. Drug Treatments
(10)
Adult
(9)
Aged
(9)
Antineoplastic Agents
(9)
Male
(9)
Treatment Outcome
(7)
Chemotherapy
(6)
Antibodies, Monoclonal - Therapeutic Use
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Breast Neoplasms - Drug Therapy
(5)
Cancer Research
(5)
Survival Analysis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2 -Overexpressing Metastatic Breast Cancer

Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/β2-Microglobulin DNA-Liposome Complex, in Patients with Metastatic Melanoma

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Randomized Trial of a Slow-Release Versus a Standard Formulation of Cytarabine for the Intrathecal Treatment of Lymphomatous Meningitis

Abstract CT026: Phase I trial of HuMab-5B1 (MVT-5873), a novel monoclonal antibody targeting sLea, in patients with advanced pancreatic cancer and other CA19-9 positive malignancies

PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

Abstract LB-B25: Preliminary phase I data comparing HuMab-5B1 (MVT-5873), a monoclonal antibody targeting sLea, as a single agent and in combination with first line nab-paclitaxel and gemcitabine in patients with CA19-9 positive pancreatic cancer

Targeting Hypoxia and AKR1C3 with PR104 in Patients with Acute Leukemia

Abstract B278: PR610: A novel hypoxia-selective tyrosine kinase inhibitor in phase I clinical trial

Novel immunologic and biologic therapies for breast cancer

Targeted Antiangiogenic Therapy for Cancer Using Vitaxin: A Humanized Monoclonal Antibody to the Integrin ανβ3

Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21

RAS gene activation in acute myelogenous leukemia: Analysis by in vitro amplification and dna base sequence determination

RAS gene product expression in blood and marrow smears of patients with acute leukemia: Importance of fixation

Rapid and sensitive high-performance liquid chromatographic assay for novobiocin in human serum

Reduced Cardiotoxicity and Preserved Antitumor Efficacy of Liposome-Encapsulated Doxorubicin and Cyclophosphamide Compared With Conventional Doxorubicin and Cyclophosphamide in a Randomized, Multicenter Trial of Metastatic Breast Cancer

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

Suchergebnisse filtern